Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, su...
Use this information to figure out if this company is an ideal customer for you.
475.230.2596
121 Seaport Blvd
Boston, 02210
The most common Alexion Pharmaceuticals Inc. email format is [first].[last] (ex. john.doe@alexion.com), currently being used by 99% of Alexion Pharmaceuticals Inc. business email addresses. There are 25 email formats used by Alexion Pharmaceuticals Inc..
Alexion Pharmaceuticals Inc.'s CEO is Michael Kishbauch
Alexion Pharmaceuticals Inc.'s CMO is Declan Dunne
Alexion Pharmaceuticals Inc.'s CFO is Michael Brandon
Alexion Pharmaceuticals Inc.'s HQ is located at 121 Seaport Blvd, Boston
Alexion Pharmaceuticals Inc.'s phone number is 475.230.2596
Alexion Pharmaceuticals Inc.'s official website is alexion.com
Alexion Pharmaceuticals Inc.'s revenue is $1B+
Alexion Pharmaceuticals Inc. has 10,001+ employees
Alexion Pharmaceuticals Inc. is in the industry of: Pharmaceuticals